| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium ion binding | 1.25e-04 | 14 | 24 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.42e-04 | 26 | 24 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 4.42e-04 | 26 | 24 | 2 | GO:0031420 | |
| GeneOntologyMolecularFunction | sodium channel activity | 1.77e-03 | 52 | 24 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 2.83e-03 | 66 | 24 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 2.83e-03 | 66 | 24 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.69e-03 | 262 | 24 | 3 | GO:0140097 | |
| GeneOntologyMolecularFunction | histone binding | 3.81e-03 | 265 | 24 | 3 | GO:0042393 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.70e-04 | 17 | 24 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | sodium channel complex | 5.03e-04 | 29 | 24 | 2 | GO:0034706 | |
| HumanPheno | Focal hemiclonic seizure | 1.68e-05 | 25 | 11 | 3 | HP:0006813 | |
| HumanPheno | Focal clonic seizure | 8.22e-05 | 42 | 11 | 3 | HP:0002266 | |
| MousePheno | absent anterior visceral endoderm | 4.94e-05 | 7 | 22 | 2 | MP:0012159 | |
| Domain | Na_trans_cytopl | 2.37e-05 | 6 | 24 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 2.37e-05 | 6 | 24 | 2 | IPR024583 | |
| Domain | Na_channel_asu | 7.08e-05 | 10 | 24 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 7.08e-05 | 10 | 24 | 2 | IPR010526 | |
| Domain | Na_trans_assoc | 7.08e-05 | 10 | 24 | 2 | PF06512 | |
| Domain | - | 2.29e-04 | 449 | 24 | 5 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 2.53e-04 | 459 | 24 | 5 | IPR013083 | |
| Domain | ZF_RING_2 | 5.25e-04 | 298 | 24 | 4 | PS50089 | |
| Domain | RING | 5.72e-04 | 305 | 24 | 4 | SM00184 | |
| Domain | Znf_RING | 7.35e-04 | 326 | 24 | 4 | IPR001841 | |
| Domain | Channel_four-helix_dom | 2.42e-03 | 57 | 24 | 2 | IPR027359 | |
| Domain | - | 2.42e-03 | 57 | 24 | 2 | 1.20.120.350 | |
| Domain | C1 | 3.13e-03 | 65 | 24 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 3.23e-03 | 66 | 24 | 2 | IPR002219 | |
| Domain | IQ | 3.73e-03 | 71 | 24 | 2 | PF00612 | |
| Domain | PHD | 4.15e-03 | 75 | 24 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 4.59e-03 | 79 | 24 | 2 | IPR019787 | |
| Domain | IQ | 4.82e-03 | 81 | 24 | 2 | SM00015 | |
| Domain | - | 5.50e-03 | 283 | 24 | 3 | 1.10.10.60 | |
| Domain | PHD | 5.79e-03 | 89 | 24 | 2 | SM00249 | |
| Domain | IQ_motif_EF-hand-BS | 5.92e-03 | 90 | 24 | 2 | IPR000048 | |
| Domain | ZF_RING_1 | 5.95e-03 | 291 | 24 | 3 | PS00518 | |
| Domain | Znf_PHD | 6.04e-03 | 91 | 24 | 2 | IPR001965 | |
| Domain | IQ | 6.30e-03 | 93 | 24 | 2 | PS50096 | |
| Domain | ZF_PHD_2 | 6.57e-03 | 95 | 24 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 6.70e-03 | 96 | 24 | 2 | PS01359 | |
| Pubmed | 2.47e-07 | 1014 | 24 | 8 | 32416067 | ||
| Pubmed | 4.17e-07 | 225 | 24 | 5 | 12168954 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 4.56e-07 | 2 | 24 | 2 | 27174182 | |
| Pubmed | 6.38e-07 | 469 | 24 | 6 | 27634302 | ||
| Pubmed | 7.15e-07 | 251 | 24 | 5 | 31076518 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 15302875 | ||
| Pubmed | RE-IIBP Methylates H3K79 and Induces MEIS1-mediated Apoptosis via H2BK120 Ubiquitination by RNF20. | 1.37e-06 | 3 | 24 | 2 | 26206755 | |
| Pubmed | 1.59e-06 | 549 | 24 | 6 | 38280479 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 3.34e-06 | 989 | 24 | 7 | 36424410 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 4.56e-06 | 5 | 24 | 2 | 22875929 | |
| Pubmed | 6.83e-06 | 6 | 24 | 2 | 16029194 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 6.83e-06 | 6 | 24 | 2 | 23652591 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 9.88e-06 | 430 | 24 | 5 | 35044719 | |
| Pubmed | Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. | 1.27e-05 | 8 | 24 | 2 | 21447625 | |
| Pubmed | 1.64e-05 | 9 | 24 | 2 | 16382098 | ||
| Pubmed | A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. | 1.64e-05 | 9 | 24 | 2 | 16728976 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | 1.83e-05 | 1284 | 24 | 7 | 17353931 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.93e-05 | 1294 | 24 | 7 | 30804502 | |
| Pubmed | 2.85e-05 | 86 | 24 | 3 | 37253089 | ||
| Pubmed | 2.90e-05 | 538 | 24 | 5 | 28524877 | ||
| Pubmed | 3.00e-05 | 12 | 24 | 2 | 11867214 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.28e-05 | 934 | 24 | 6 | 33916271 | |
| Pubmed | 3.54e-05 | 13 | 24 | 2 | 15123669 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 4.01e-05 | 283 | 24 | 4 | 30585729 | |
| Pubmed | SHP-1 dephosphorylates histone H2B to facilitate its ubiquitination during transcription. | 5.44e-05 | 16 | 24 | 2 | 35938192 | |
| Pubmed | 6.94e-05 | 18 | 24 | 2 | 19410543 | ||
| Pubmed | 7.26e-05 | 653 | 24 | 5 | 22586326 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 8.26e-05 | 341 | 24 | 4 | 32971831 | |
| Pubmed | 8.27e-05 | 1103 | 24 | 6 | 34189442 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 8.36e-05 | 1105 | 24 | 6 | 35748872 | |
| Pubmed | 1.05e-04 | 22 | 24 | 2 | 17893145 | ||
| Pubmed | Gene expression in the developing mouse retina by EST sequencing and microarray analysis. | 1.27e-04 | 142 | 24 | 3 | 11812828 | |
| Pubmed | 1.36e-04 | 25 | 24 | 2 | 12522145 | ||
| Pubmed | 1.59e-04 | 27 | 24 | 2 | 18685082 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.61e-04 | 774 | 24 | 5 | 15302935 | |
| Pubmed | 1.67e-04 | 156 | 24 | 3 | 37108203 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.52e-04 | 1353 | 24 | 6 | 29467282 | |
| Pubmed | A quantitative telomeric chromatin isolation protocol identifies different telomeric states. | 2.53e-04 | 34 | 24 | 2 | 24270157 | |
| Pubmed | A cryptic Tudor domain links BRWD2/PHIP to COMPASS-mediated histone H3K4 methylation. | 2.83e-04 | 36 | 24 | 2 | 29089422 | |
| Pubmed | 2.87e-04 | 472 | 24 | 4 | 38943005 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | 3.21e-04 | 1415 | 24 | 6 | 28515276 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 3.41e-04 | 910 | 24 | 5 | 36736316 | |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 3.44e-04 | 495 | 24 | 4 | 27705803 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.49e-04 | 497 | 24 | 4 | 36774506 | |
| Pubmed | 3.55e-04 | 1442 | 24 | 6 | 35575683 | ||
| Pubmed | 3.57e-04 | 202 | 24 | 3 | 24639526 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 3.62e-04 | 203 | 24 | 3 | 22083510 | |
| Pubmed | 3.73e-04 | 506 | 24 | 4 | 30890647 | ||
| Pubmed | 3.86e-04 | 42 | 24 | 2 | 23444366 | ||
| Pubmed | 4.19e-04 | 1487 | 24 | 6 | 33957083 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.22e-04 | 1489 | 24 | 6 | 28611215 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.23e-04 | 954 | 24 | 5 | 36373674 | |
| Pubmed | 4.42e-04 | 529 | 24 | 4 | 14621295 | ||
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 4.54e-04 | 533 | 24 | 4 | 30554943 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.58e-04 | 220 | 24 | 3 | 35785414 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.84e-04 | 1024 | 24 | 5 | 24711643 | |
| Interaction | TERF2IP interactions | 3.63e-05 | 552 | 24 | 6 | int:TERF2IP | |
| Interaction | CEBPA interactions | 6.25e-05 | 1245 | 24 | 8 | int:CEBPA | |
| Interaction | CSNK2A1 interactions | 8.99e-05 | 956 | 24 | 7 | int:CSNK2A1 | |
| Interaction | PAF1 interactions | 1.11e-04 | 214 | 24 | 4 | int:PAF1 | |
| Interaction | BRD2 interactions | 1.30e-04 | 429 | 24 | 5 | int:BRD2 | |
| Interaction | SCN11A interactions | 1.41e-04 | 15 | 24 | 2 | int:SCN11A | |
| Interaction | CTR9 interactions | 1.54e-04 | 233 | 24 | 4 | int:CTR9 | |
| Interaction | HDAC1 interactions | 2.26e-04 | 1108 | 24 | 7 | int:HDAC1 | |
| Interaction | POLR1G interactions | 2.39e-04 | 489 | 24 | 5 | int:POLR1G | |
| Interaction | BRD3 interactions | 2.51e-04 | 494 | 24 | 5 | int:BRD3 | |
| Cytoband | 14q32.3 | 1.18e-05 | 10 | 24 | 2 | 14q32.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18p11 | 5.38e-03 | 210 | 24 | 2 | chr18p11 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.00e-05 | 9 | 14 | 2 | 1203 | |
| GeneFamily | PHD finger proteins | 2.14e-03 | 90 | 14 | 2 | 88 | |
| GeneFamily | Ring finger proteins | 1.86e-02 | 275 | 14 | 2 | 58 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | 5.44e-06 | 513 | 24 | 6 | M39069 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 2.20e-05 | 656 | 24 | 6 | M18979 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 2.36e-05 | 389 | 24 | 5 | M39102 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 2.54e-05 | 190 | 24 | 4 | M8457 | |
| Coexpression | GSE20727_CTRL_VS_H2O2_TREATED_DC_DN | 2.87e-05 | 196 | 24 | 4 | M9243 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 3.10e-05 | 200 | 24 | 4 | M9439 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | 3.50e-05 | 1492 | 24 | 8 | M40023 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.59e-05 | 466 | 24 | 5 | M13522 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | 9.69e-05 | 856 | 24 | 6 | M4500 | |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.29e-04 | 289 | 24 | 4 | M2196 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.49e-04 | 300 | 24 | 4 | M8702 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | 1.61e-04 | 584 | 24 | 5 | M39068 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.96e-04 | 143 | 24 | 3 | M9149 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBGABA | 3.81e-04 | 703 | 24 | 5 | M39070 | |
| Coexpression | ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP | 5.16e-04 | 173 | 24 | 3 | M2480 | |
| Coexpression | GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP | 6.38e-04 | 186 | 24 | 3 | M8012 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 6.68e-04 | 189 | 24 | 3 | M3112 | |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP | 6.78e-04 | 190 | 24 | 3 | M18436 | |
| Coexpression | GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP | 6.89e-04 | 191 | 24 | 3 | M6495 | |
| Coexpression | GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN | 7.31e-04 | 195 | 24 | 3 | M9824 | |
| Coexpression | GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 7.42e-04 | 196 | 24 | 3 | M9241 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 7.53e-04 | 197 | 24 | 3 | M5347 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN | 7.64e-04 | 198 | 24 | 3 | M8628 | |
| Coexpression | GSE17721_0.5H_VS_12H_LPS_BMDC_UP | 7.64e-04 | 198 | 24 | 3 | M4067 | |
| Coexpression | GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP | 7.64e-04 | 198 | 24 | 3 | M3249 | |
| Coexpression | GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN | 7.76e-04 | 199 | 24 | 3 | M9443 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP | 7.76e-04 | 199 | 24 | 3 | M7710 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN | 7.87e-04 | 200 | 24 | 3 | M8543 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP | 7.87e-04 | 200 | 24 | 3 | M6836 | |
| Coexpression | GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN | 7.87e-04 | 200 | 24 | 3 | M4318 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | 1.61e-06 | 795 | 24 | 8 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.19e-06 | 379 | 24 | 6 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 4.47e-06 | 402 | 24 | 6 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | 4.62e-05 | 1257 | 24 | 8 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.11e-05 | 385 | 24 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 7.14e-05 | 201 | 24 | 4 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | 8.41e-05 | 412 | 24 | 5 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | 1.32e-04 | 1459 | 24 | 8 | facebase_RNAseq_e10.5_Emin_LatNas_2500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | 1.74e-04 | 772 | 24 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | 1.76e-04 | 774 | 24 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#4_top-relative-expression-ranked_500 | 2.27e-04 | 106 | 24 | 3 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 2.38e-04 | 818 | 24 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#3_top-relative-expression-ranked_500 | 2.96e-04 | 116 | 24 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_500 | 3.43e-04 | 122 | 24 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | 3.63e-04 | 564 | 24 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#1_top-relative-expression-ranked_200 | 5.58e-04 | 31 | 24 | 2 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_200_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.69e-04 | 375 | 24 | 4 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#5_top-relative-expression-ranked_500 | 8.40e-04 | 38 | 24 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500_k5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.55e-08 | 200 | 24 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 6.55e-08 | 200 | 24 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-06 | 182 | 24 | 4 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-06 | 185 | 24 | 4 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 195 | 24 | 4 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-06 | 195 | 24 | 4 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-06 | 196 | 24 | 4 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.61e-06 | 198 | 24 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.76e-06 | 200 | 24 | 4 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 7.84e-05 | 156 | 24 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-05 | 165 | 24 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.26e-05 | 165 | 24 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-04 | 182 | 24 | 3 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 183 | 24 | 3 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 183 | 24 | 3 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-04 | 183 | 24 | 3 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-04 | 184 | 24 | 3 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 184 | 24 | 3 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 185 | 24 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-04 | 185 | 24 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 185 | 24 | 3 | e913c64f9b4873443d88dce270f0b7b6d1b4cbce | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 187 | 24 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.36e-04 | 188 | 24 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 188 | 24 | 3 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 1803b1e7c36285f9eaabc3c6e9a9752c5908db3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | 7b0d42a877540dbb346a76a62403e0d5d3e07fa6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-04 | 191 | 24 | 3 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | cd854b9c426924fdc84bf7f411f6dea447143e79 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.45e-04 | 192 | 24 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-04 | 192 | 24 | 3 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LA-14._Fibroblast_III|LA / Chamber and Cluster_Paper | 1.47e-04 | 193 | 24 | 3 | 7426c291bac59e539c427bcaae18abc7d397d44e | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 1.49e-04 | 194 | 24 | 3 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 1.49e-04 | 194 | 24 | 3 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 194 | 24 | 3 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-04 | 194 | 24 | 3 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.52e-04 | 195 | 24 | 3 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 195 | 24 | 3 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Neuronal-Subcortical|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.54e-04 | 196 | 24 | 3 | bf8fe28193348342987d361c8e8b9e1d6d542678 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 197 | 24 | 3 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.56e-04 | 197 | 24 | 3 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 197 | 24 | 3 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 197 | 24 | 3 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.59e-04 | 198 | 24 | 3 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-04 | 198 | 24 | 3 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.61e-04 | 199 | 24 | 3 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.61e-04 | 199 | 24 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 418821561c8949ed96c07f9bea3aabc287c04ff1 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.63e-04 | 200 | 24 | 3 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.63e-04 | 200 | 24 | 3 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Cortical_neuron|1m / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 0185b4ad6b512d24efff806460ee1b57e42096e9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.47e-03 | 106 | 24 | 2 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.47e-03 | 106 | 24 | 2 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.47e-03 | 106 | 24 | 2 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.33e-03 | 134 | 24 | 2 | 0e3f37ef041b751ed45060b5ce39385a2731370b | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 2.36e-03 | 135 | 24 | 2 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 137 | 24 | 2 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 137 | 24 | 2 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.47e-03 | 138 | 24 | 2 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.50e-03 | 139 | 24 | 2 | 7c02caed5b9baf233bd6fb9a453708b3e157c790 | |
| ToppCell | CTRL-Lymphoid-pDC|CTRL / Disease state, Lineage and Cell class | 2.50e-03 | 139 | 24 | 2 | bbc10812b0c5b8c85e78171c12316becde8895c3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-03 | 146 | 24 | 2 | ec1f793409d1a81c0f9323eb3c82ffe01dae0e44 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.75e-03 | 146 | 24 | 2 | bee5074c29b132180d35f57d307e342efa9b8cd1 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.83e-03 | 148 | 24 | 2 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | Ionocyte|World / shred by cell class for nasal brushing | 3.06e-03 | 154 | 24 | 2 | 6b78fb0c96fc7b5e901c39b3424f4aa8d0a6b9cf | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-03 | 155 | 24 | 2 | 583cfaa41c755c63aee312eb442e9d97f645d5f7 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.14e-03 | 156 | 24 | 2 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 3.14e-03 | 156 | 24 | 2 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.18e-03 | 157 | 24 | 2 | eea53cf8d8a607264e1ee00b7a97c94bcf2ac80d | |
| ToppCell | IPF-Epithelial-Ionocyte|Epithelial / Disease state, Lineage and Cell class | 3.21e-03 | 158 | 24 | 2 | 67adf625a959444762d32268b3b7441f6f8b3b8c | |
| ToppCell | Control-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.25e-03 | 159 | 24 | 2 | 6f50c381cd8a26a5a90bf0ce909713cea96910d7 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-03 | 159 | 24 | 2 | cbb331eb689d8cea9e1146ba85e0a05d23301c47 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.25e-03 | 159 | 24 | 2 | 330ecbba97d47bc818a5e8d1d84b05d056bd831e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.25e-03 | 159 | 24 | 2 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV5/7_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-03 | 159 | 24 | 2 | 006076bac619bf14a4c98f1158ac336bd9908914 | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 3.29e-03 | 160 | 24 | 2 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.29e-03 | 160 | 24 | 2 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.29e-03 | 160 | 24 | 2 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | IPF-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 3.34e-03 | 161 | 24 | 2 | f1cd5c938cdc08ad8995371b72493850a6cf277a | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 3.34e-03 | 161 | 24 | 2 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-03 | 162 | 24 | 2 | 40265af9b36fd144a8577b8dacccd4fc0888a593 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-03 | 162 | 24 | 2 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-03 | 162 | 24 | 2 | 9522af31f6b2f3cb81b6b84bd08353eea504d1d6 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-03 | 162 | 24 | 2 | 9a18286e361e1dd18e6f943ce27db58b199fb6e4 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-03 | 162 | 24 | 2 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-03 | 162 | 24 | 2 | 86a0b9dabd150dc993bfc0f3344804de7f8e4042 | |
| ToppCell | 3'-Distal_airway-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.38e-03 | 162 | 24 | 2 | 3395e4dffdb9304d157c325e1fc0f12b433c7bd3 | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 3.38e-03 | 162 | 24 | 2 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 3.42e-03 | 163 | 24 | 2 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.42e-03 | 163 | 24 | 2 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | 367C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-03 | 164 | 24 | 2 | 1aff83fc73b4e41e6f0d4b04dbca153bcc7a3518 | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 3.46e-03 | 164 | 24 | 2 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 3.50e-03 | 165 | 24 | 2 | 7b992843bd8ef92a7a76b1d681fa84efde6f5bdd | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.50e-03 | 165 | 24 | 2 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| Disease | B Virus Infection | 1.90e-06 | 3 | 24 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 1.90e-06 | 3 | 24 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 1.90e-06 | 3 | 24 | 2 | C0019372 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.84e-05 | 10 | 24 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 4.16e-05 | 12 | 24 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 5.85e-05 | 93 | 24 | 3 | C1535926 | |
| Disease | Bladder Neoplasm | 1.97e-04 | 140 | 24 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.01e-04 | 141 | 24 | 3 | C0005684 | |
| Disease | circadian rhythm | 3.08e-04 | 163 | 24 | 3 | EFO_0004354 | |
| Disease | Intellectual Disability | 4.34e-04 | 447 | 24 | 4 | C3714756 | |
| Disease | neutrophil percentage of granulocytes | 8.17e-04 | 228 | 24 | 3 | EFO_0007994 | |
| Disease | eosinophil percentage of granulocytes | 8.81e-04 | 234 | 24 | 3 | EFO_0007996 | |
| Disease | congenital heart disease (implicated_via_orthology) | 1.44e-03 | 69 | 24 | 2 | DOID:1682 (implicated_via_orthology) | |
| Disease | waist-hip ratio | 2.70e-03 | 1226 | 24 | 5 | EFO_0004343 | |
| Disease | sleep duration | 3.06e-03 | 362 | 24 | 3 | EFO_0005271 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DEPAELKPDSEDLSS | 531 | Q5VTR2 | |
| LASPEEDPSEDDSIK | 416 | O14529 | |
| SLEKDSDDKTPDDDP | 601 | Q12830 | |
| SDDKTPDDDPEQGKS | 606 | Q12830 | |
| SPLPSEKSDEDDDKL | 1356 | O14646 | |
| DSDIEEEEDPKTSPK | 166 | Q14206 | |
| SDESDSSSEEEKKPP | 326 | Q14978 | |
| SDSDSSEDDEAPSKP | 366 | Q14978 | |
| ASPSTGDDDDPDKDK | 256 | O00470 | |
| PSDGLEEKLDSDDPS | 2681 | Q8NEZ4 | |
| EEKLDSDDPSVKELD | 2686 | Q8NEZ4 | |
| KDDADSPTEDGDKPR | 101 | O60291 | |
| PDQDFDKEPDSDSTK | 1661 | Q9Y5S2 | |
| DSKAPKPEDIDEEDD | 126 | Q96K17 | |
| ESDDDLDDKPSPIKK | 716 | Q9ULH1 | |
| DSDVPDDKSDDSDVP | 211 | Q96QF7 | |
| DSEAPDDKSDDSDVP | 301 | Q96QF7 | |
| DDKSDDSDVPEDKSD | 306 | Q96QF7 | |
| DKDTDSTKEPLDDLF | 166 | Q07866 | |
| SSDEEEEKEEIPPKS | 336 | Q92541 | |
| DDPCFPSKLKDEDDE | 441 | A6NHR9 | |
| DDDEEAPKPSSDLEA | 41 | Q15858 | |
| SDSDEEEESKEPPIK | 181 | O75592 | |
| PVASASDPEKDEDDD | 2096 | O60673 | |
| EDDSPKSLEEATPSK | 416 | Q86VQ3 | |
| DGSHREDDEDSKPKP | 41 | Q9UQD0 | |
| EDDEDSKPKPNSDLE | 46 | Q9UQD0 | |
| DSETEKPEADDPKDN | 76 | Q9UHR5 | |
| EASNDEDDPKDKTLP | 66 | Q5SXM2 | |
| FKPPEDSQDDESDSD | 301 | Q13769 |